CD4 and bladder transitional cell carcinoma: Finally, we validated the clinical specimens of BLCA for T-cell markers (CD3 and CD4) and B-cell markers (CD20) and noted a significant increase in T- and B-cell infiltration in BLCA tissues compared with that in paratumor tissues (P < 0.001; Fig. 5).